Getinge (OTCMKTS:GNGBY – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $19.9850, but opened at $20.74. Getinge shares last traded at $20.74, with a volume of 1,047 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised shares of Getinge to a “hold” rating in a report on Thursday, April 23rd. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.
Get Our Latest Stock Report on Getinge
Getinge Stock Performance
About Getinge
Getinge AB is a global medical technology company that develops, manufactures and markets products and systems for hospitals and life sciences institutions. The company’s offerings focus on critical care, surgical workflows and infection control, aiming to improve clinical outcomes and operational efficiency. Getinge’s solutions support a range of applications from intensive care and cardiovascular treatments to sterile reprocessing of surgical instruments.
The company’s product portfolio includes sterilization and disinfection equipment, surgical tables and lights, ventilation systems, heart-lung machines and extracorporeal membrane oxygenation (ECMO) devices.
Recommended Stories
- Five stocks we like better than Getinge
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for Getinge Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge and related companies with MarketBeat.com's FREE daily email newsletter.
